Although various agents can help relieve the pain, itching, and inflammation, there is no cure for pediatric eczema.
They are usually categorized as first-, second-, or third-degree burns, depending upon their severity.
Acute or chronic adverse dermatologic reactions caused by medication exposure are common.
Melanoma, the fifth most common cancer in the United States, accounts
for fewer than 5% of skin cancer cases but is the most serious form of
the disease, causing up to 75% of skin cancer–related deaths.
The treatment of systemic sclerosis and its complications
is complex and requires careful evaluation and collaboration between the
pharmacist and other practitioners.
Spider veins, hair loss, and cold sores are among the variety of skin conditions afflicting millions of Americans.
Public awareness of
the detriments of sun exposure and the necessity of using sunscreen for
skin protection has increased.
Vitiligo is a pigment disorder that involves the skin, the hair, and occasionally the mucous membranes.
Melanoma is the least common but most dangerous form of skin cancer.
Despite numerous critical instructions and warnings on the labels,
research has shown that these products are often used incorrectly.
The connection between food intake and this condition remains
uncertain, but regulation of carbohydrate consumption is safe and may
be beneficial in combination with other regimens.
Systemic and topical therapies, both current and in development, are
showing promise for the prevention and management of this growing
health concern.
Patients should be educated about the risk of burns and other
problems that could result from wearing topical delivery systems during
MRI scanning or while exposed to the sun or excessive heat.
Ambulatory medical care in a physician's office is the largest and most widely used segment of the U.S. health care system, and in 2004 it comprised 25% of all health care spending.
A 41-year-old man presents to a dermatology clinic with a three-day history of pruritic lesions...
A task force of the National Psoriasis Foundation Medical Board discovered that "people with more severe cases of psoriasis appear to have an increased incidence of psoriatic arthritis, cardiovascular disease, hypertension, diabetes, cancer, depression, obesity, and even other immune-related conditions."
Although the first sunscreen product was developed in 1928, it was not until the 1940s that the FDA began to regulate these products.
Approximately 25 percent of Americans are affected by chronic venous insufficiency.
Raynaud's phenomenon was named for French physician Maurice Raynaud (1834-1881) and was first described in 1862.
A mong all adverse reactions to medications, 6% to 10% are allergic in nature.
Rashes are ubiquitous in the American population, being one of the more common reasons for pharmacy and physician visits.
Keratosis pilaris is a common, easily recognized, benign skin disorder that is characterized by patches of tiny, hard bumps resembling small pimples on the skin’s surface.
ABSTRACT: Despite advancements in chemotherapy treatments, dermatologic complications continue to be associated with chemotherapeutic agents.
Rosacea is a common, chronic skin disorder characterized by transient or persistent central facial erythema, telangiectasia (visible blood vessels), inflammatory episodes with papules and pustules, and, in severe cases, rhinophyma.
With the advent of warmer weather, seasoned pharmacists anticipate an onslaught of patients seeking assistance with summer-related illnesses, such as sunburn, poison ivy, and insect-related problems.
In the United States, the most common types of cancer are those affecting the skin, and most skin cancers occur in the elderly population.
In the United States, the indoor tanning industry (ITI)--currently estimated at $5 billion--inaccurately advertises vitamin D production and UV (ultraviolet) protection as health benefits of tanning.
Cheloid, derived from the Greek word chele (meaning "crab claw"), refers to the way in which lesions grow laterally from an original scar into normal tissue.
Topical isotretinoin (Retin-A) was introduced to the market in the early 1970s.
